An observational study in Amebic Liver Abscess, sponsored by Universidad Autonoma de San Luis Potosí. Completed at 2 sites in Mexico. Open to participants aged 16 Years to 80 Years. Per ClinicalTrials.gov, last updated 2008-03-24.
Sponsored by Universidad Autonoma de San Luis Potosí · Observational
Amebic liver abscess is the most frequent extra-intestinal form of the amoebiasis; actually the factors for predicting failure in the medical treatment are not clear. We conducted trial for determining the clinical value of paraclinical factor in this issue.
149 studies on the registry are indexed under Abscess; 32 are open to participants now.
This study's enrollment of 40 is below the median of 109 across 39 observational studies indexed under Abscess.
Browse Abscess studies →Universidad Autonoma de San Luis Potosí is the lead sponsor of 40 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
sequential patients with clinical, ultrasonographic and serologic diagnosis (ELISA) of amebic liver abscess
Exclusion Criteria:
Response to medical treatment
Failure to medical treatment (surgery or percutaneous resolution)
Failure of medical treatment
Time frame: Day 4
This study is completed, as verified in Mar 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidad Autonoma de San Luis Potosí